Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.
<h4>Background</h4>Whether seroresponse to a vaccine such as hepatitis B virus (HBV) vaccine can provide a measure of the functional immune status of HIV-infected persons is unknown.This study evaluated the relationship between HBV vaccine seroresponses and progression to clinical AIDS o...
Guardado en:
Autores principales: | Michael L Landrum, Katherine Huppler Hullsiek, Robert J O'Connell, Helen M Chun, Anuradha Ganesan, Jason F Okulicz, Tahaniyat Lalani, Amy C Weintrob, Nancy F Crum-Cianflone, Brian K Agan, Infectious Disease Clinical Research Program HIV Working Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06a2c8bb9b35493f8f0f10b0cfbd940f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.
por: Jason F Okulicz, et al.
Publicado: (2014) -
High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
por: Jason M Cota, et al.
Publicado: (2021) -
A National Rural Postsecondary Research Agenda
por: National Rural Postsecondary Research Agenda Working Group
Publicado: (2021) -
Probabilistic modelling of effects of antibiotics and calendar time on transmission of healthcare-associated infection
por: Mirjam Laager, et al.
Publicado: (2021) -
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies [version 2; peer review: 3 approved]
por: Eleanor M. Rees, et al.
Publicado: (2021)